BIO-key International
BKYI
10 hedge funds and large institutions have $227K invested in BIO-key International in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
147% more capital invested
Capital invested by funds: $91.8K → $227K (+$135K)
0.24% more ownership
Funds ownership: 0.16% → 0.39% (+0.24%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
29% less funds holding
Funds holding: 14 → 10 (-4)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$153K |
| 2 |
Citigroup
New York
|
+$31.3K |
| 3 |
VF
Virtu Financial
New York
|
+$12.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.7K |
| 5 |
Morgan Stanley
New York
|
+$1.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$17.1K |
| 2 |
Jane Street
New York
|
-$13.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.05K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$6K |
| 5 |
SRCM
Signature Resources Capital Management
Newport Beach,
California
|
-$539 |
BKYI Hedge Fund Activity: Q1 2026 in Review
10 institutional investors reported a position in BIO-key International (BKYI) for Q1 2026, worth a combined $227K — up 147% from $91.8K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BKYI and 4 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $153K. The largest seller was Citadel Advisors, exiting entirely with an estimated $17.1K sold.
- 10 institutional investors held BIO-key International (BKYI) as of Q1 2026, down from 14 in Q4 2025.
- Funds reported $227K of BIO-key International stock for Q1 2026, up 147% quarter-over-quarter.
- 4 funds opened new BIO-key International positions in Q1 2026 and 6 closed out, a net change of -2 holders.
- The largest BIO-key International buyer in Q1 2026 was Geode Capital Management, an estimated $153K added.
- The largest BIO-key International seller in Q1 2026 was Citadel Advisors, an estimated $17.1K sold.
Based on aggregated 13F filings for Q1 2026.